Poster presentations across all programs, including data from HELIOS long-term extension trial of bitopertin in ...

Panelists discuss how managing advanced polycythemia vera requires tailored approaches beyond hydroxyurea when patients show resistance (persistent hematocrit >45%, elevated white blood cell counts, ...

Panelists discuss how polycythemia vera treatment follows a risk-stratified approach, with all patients receiving daily aspirin and phlebotomies to maintain hematocrit below 45%, while high-risk ...

Seven days after returning from a trip to Argentina, a 21-year-old woman presented to her family physician with fever, myalgia, and a macular rash on both thighs. This constellation of symptoms raised ...

Machine learning identifies key biomarkers predicting hydroxyurea resistance in polycythemia vera, enhancing early treatment ...

Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera (PV) announced; full data selected for oral presentation during plenary session at ASCO on June 1stConference call t ...

Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera (PV) announced; full data selected for oral presentation during plenary session at ASCO on June 1stConference call ...

Scientists from Saratov State Medical University have developed a mini-laboratory for non-invasive blood analysis. According to the developers, this portable device will allow emergency physicians and ...